ANFFX
Price
$56.68
Change
+$4.90 (+9.46%)
Updated
Apr 9 closing price
Net Assets
30.01B
NPFCX
Price
$54.57
Change
+$3.98 (+7.87%)
Updated
Apr 9 closing price
Net Assets
122.54B
Ad is loading...

ANFFX vs NPFCX

Header iconANFFX vs NPFCX Comparison
Open Charts ANFFX vs NPFCXBanner chart's image
American Funds New Economy F1
Price$56.68
Change+$4.90 (+9.46%)
VolumeN/A
Net Assets30.01B
American Funds New Perspective C
Price$54.57
Change+$3.98 (+7.87%)
VolumeN/A
Net Assets122.54B
ANFFX vs NPFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ANFFX vs. NPFCX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANFFX is a Buy and NPFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 123B vs. ANFFX (30B). ANFFX (0.00) and NPFCX (0.00) have matching dividends . ANFFX was incepted earlier than NPFCX: ANFFX (24 years) vs NPFCX (24 years). NPFCX (1.48) is less costly to investors than ANFFX (0.79). ANFFX is a more actively managed with annual turnover of: 36.00 vs. NPFCX (24.00). ANFFX (250) and NPFCX (250) have matching initial minimum investment requirements. NPFCX annual gain was more profitable for investors over the last year : -10.63 vs. ANFFX (-13.69). NPFCX (30.30) and ANFFX (29.11) have equivalent 5 years return.
ANFFXNPFCXANFFX / NPFCX
Total Expense Ratio0.791.4853%
Annual Report Gross Expense Ratio0.791.4853%
Fund Existence24 years24 years-
Gain YTD-15.572-12.625123%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets30B123B24%
Annual Yield % from dividends0.000.00-
Returns for 1 year-13.69-10.63129%
Returns for 3 years-0.16-7.882%
Returns for 5 years29.1130.3096%
Returns for 10 years32.8134.6695%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLDD8.810.77
+9.64%
Great Lakes Dredge & Dock Corp
GMAB18.830.85
+4.73%
Genmab A/S ADS
INTR5.260.22
+4.46%
Inter & Co
ALDX1.930.01
+0.78%
Aldeyra Therapeutics
SONN1.25N/A
+0.34%
Sonnet BioTherapeutics Holdings Inc